HALO logo
halo search icon
Merck & Co., Inc.
Merck & Co., Inc.
MRK · NYS

Merck & Co., Inc.

US$113.00

Price Arrow-1.24 (-1.085%)
20/05/2026 04:10:00 PM
All-CompaniesAll-ConsensusALL-RecommendationsHALO 200HALO 500HALO AllHALO Capital Efficiency
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Merck & Co., Inc. Overview

MRK Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

HALO Model

Mqv

Neutral

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Strong

Growth

Earnings

Very Weak

Dividends

Neutral

Quality

Capital Efficiency

Very Strong

Balance Sheet

Weak

About MRK

icon

Telephone

1.908.740.4000

icon

Address

126 East Lincoln Avenue, Rahway, NJ 07065

Description

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

MRK Price Chart

Key Stats

Market Cap

US$282.15B

PE

14.50

EV/EBITDA

10.2

Dividends Overview

DIV Yield

3.1%

Franking

N/A

Ex Dividend Date (est.)

16-Mar-26

Market Data

52 weeks range

Low 75.4 - 125.14

Trade Value (12mth)

US$302,125,645.00

1 week

2.57%

1 month

1.49%

YTD

7.32%

1 year

48.4%

All time high

134.63

Key Fundamentals

EPS 3 yr Growth

27.20%

EBITDA Margin

45.20%

Operating Cashflow

$16,472m

Free Cash Flow Return

18.10%

ROIC

20.10%

Interest Coverage

21.60

Quick Ratio

1.30

Other Data

Shares Outstanding (Fully Diluted)

2,472m

HALO Sector

Healthcare

Next Company Report Date

04-Feb-27

Next Ex Dividend Date

16-Mar-26

Next Dividend Pay Date

07-Apr-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

MRK Announcements

Latest Announcements

DateAnnouncements
21 May 26
21 May 26
18 May 26
05 May 26
05 May 26

MRK Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock0.146.767.3locklocklock
EPS (Fully Diluted)
$locklocklocklock0.146.747.28locklocklock
Growth
%locklocklocklock-97.54,597.97.9locklocklock
PE
Xlocklocklocklock760.814.814.5locklocklock
EV/EBITDA
Xlocklocklocklock44.61110.2locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

16-Mar-26

DIV Yield

3.1%

Franking Level

N/A

DPSg

5.1%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
The current share price of Merck & Co., Inc. (MRK:NYS) is USD$113.00.
What is the 52-week high share price for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
The 52-week high share price for Merck & Co., Inc. (MRK:NYS) is USD$125.14.
What is the 52-week low share price for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
The 52-week low share price for Merck & Co., Inc. (MRK:NYS) is USD$75.40.
What is the dividend yield for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
The current TTM dividend payout for Merck & Co., Inc. (MRK:NYS) is 3.10.
What was Merck & Co., Inc. (MRK:NYS) last dividend payment?
Halo FAQ
The last dividend payment of Merck & Co., Inc. (MRK:NYS) is USD$0.85.
What is the franking level for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
Merck & Co., Inc. (MRK:NYS) has a franking level of 0.00%.
In which sector is Merck & Co., Inc. (MRK:NYS) classified?
Halo FAQ
Merck & Co., Inc. (MRK:NYS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Merck & Co., Inc. (MRK:NYS)?
Halo FAQ
The current P/E ratio for Merck & Co., Inc. (MRK:NYS) is 14.50.

See beyond the curve.

One solution for research, investing and portfolio management.